Omega Fund Management, LLC Replimune Group, Inc. Transaction History

Omega Fund Management, LLC

$36.7 Million
Q3 2025

A detailed history of Omega Fund Management, LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Omega Fund Management, LLC holds 248,672 shares of REPL stock, worth $2.24 Million. This represents 2.84% of its overall portfolio holdings.

Number of Shares

248,672

Previous 1,975,203 87.41%

Holding current value

$2.24 Million

Previous $18.3 Million 94.33%

% of portfolio

2.84%

Previous 39.5%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$2.81 - $12.63 $4.85 Million - $21.8 Million	-1,726,531 Reduced 87.41%	248,672 $1.04 Million
Q4 2024 Feb 14, 2025	SELL	$10.54 - $14.93 $5.12 Million - $7.26 Million	-486,116 Reduced 19.75%	1,975,203 $23.9 Million
Q2 2024 Aug 14, 2024	SELL	$5.01 - $9.46 $2.71 Million - $5.11 Million	-540,000 Reduced 17.99%	2,461,319 $22.2 Million
Q2 2023 Aug 14, 2023	SELL	$15.65 - $24.1 $764,784 - $1.18 Million	-48,868 Reduced 1.6%	3,001,319 $69.7 Million
Q1 2023 May 15, 2023	SELL	$17.48 - $29.09 $5.45 Million - $9.06 Million	-311,619 Reduced 9.27%	3,050,187 $53.9 Million

Q4 2022 Feb 13, 2023	SELL	$17.09 - $27.91 $15.8 Million - $25.9 Million	-926,348 Reduced 21.6%	3,361,806 $91.4 Million
Q3 2022 Nov 14, 2022	SELL	$15.6 - $21.15 $6.01 Million - $8.15 Million	-385,226 Reduced 8.24%	4,288,154 $74.1 Million
Q1 2022 May 13, 2022	SELL	$15.24 - $29.75 $1.37 Million - $2.68 Million	-90,000 Reduced 1.89%	4,673,380 $79.4 Million
Q4 2021 Feb 14, 2022	SELL	$25.43 - $34.25 $3.37 Million - $4.54 Million	-132,694 Reduced 2.71%	4,763,380 $129 Million
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $3.25 Million - $4.44 Million	-112,171 Reduced 2.24%	4,896,074 $145 Million
Q1 2021 May 17, 2021	SELL	$30.22 - $45.57 $2.01 Million - $3.03 Million	-66,538 Reduced 1.31%	5,008,245 $153 Million
Q4 2020 Feb 16, 2021	SELL	$23.5 - $52.65 $6.35 Million - $14.2 Million	-270,188 Reduced 5.05%	5,074,783 $194 Million
Q2 2020 Aug 17, 2020	BUY	$9.76 - $25.95 $209,996 - $558,340	21,516 Added 0.4%	5,344,971 $132 Million
Q4 2019 Feb 13, 2020	BUY	$11.61 - $17.21 $2.55 Million - $3.79 Million	220,000 Added 4.31%	5,323,455 $76.1 Million
Q3 2018 Nov 07, 2018	BUY	$14.99 - $22.14 $76.5 Million - $113 Million	5,103,455 New	5,103,455 $82.2 Million

Others Institutions Holding REPL

# of Institutions

193

Shares Held

80.4M

Call Options Held

8.69M

Put Options Held

2.28M

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $443M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Omega Fund Management, LLC with notifications on news.

Account

Omega Fund Management, LLC Replimune Group, Inc. Transaction History